Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 17, 2002 - Issue 2
Submit an article Journal homepage
276
Views
44
CrossRef citations to date
0
Altmetric
Research Article

Non-peptidic Chemokine Receptors Antagonists as Emerging Anti-HIV Agents

Andrea Scozzafava Università degli Studi di Firenze, Dipartimento di Chimica, Laboratorio di Chimica Bioinorganica, Via della Lastruccia, 3, Rm. 188, I-50019 Sesto Fiorentino, Firenze, Italy
,
Antonio Mastrolorenzo Università degli Studi, Dipartimento di Scienze Dermatologiche, Centro MTS, e Laboratorio di Chimica Inorganica e Bioinorganica, Via Gino Capponi 7, I-50121, Florence, Italy
&
Claudiu T. Supuran Università degli Studi di Firenze, Dipartimento di Chimica, Laboratorio di Chimica Bioinorganica, Via della Lastruccia, 3, Rm. 188, I-50019 Sesto Fiorentino, Firenze, Italy
Pages 69-76 | Published online: 30 Sep 2008

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Claudiu T Supuran. (2011) Therapeutic compounds: patent evaluation of WO2011011652A1. Expert Opinion on Therapeutic Patents 21:9, pages 1491-1495.
Read now
Hirokazu Tamamura, Hiroshi Tsutsumi, Wataru Nomura, Tomohiro Tanaka & Nobutaka Fujii. (2008) A future perspective on the development of chemokine receptor CXCR4 antagonists. Expert Opinion on Drug Discovery 3:10, pages 1155-1166.
Read now
Antonio Mastrolorenzo, Stefano Rusconi, Andrea Scozzafava & Claudiu T Supuran. (2006) Inhibitors of HIV-1 protease: 10 years after. Expert Opinion on Therapeutic Patents 16:8, pages 1067-1091.
Read now
Hirokazu Tamamura & Nobutaka Fujii. (2005) The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis. Expert Opinion on Therapeutic Targets 9:6, pages 1267-1282.
Read now
Jean-Yves Winum, Andrea Scozzafava, Jean-Louis Montero & Claudiu T Supuran. (2004) Therapeutic applications of sulfamates. Expert Opinion on Therapeutic Patents 14:9, pages 1273-1308.
Read now
Stefano Rusconi, Elisabetta Bulgheroni & Paola Citterio. (2004) Entry and fusion inhibitors of HIV. Expert Opinion on Therapeutic Patents 14:5, pages 733-748.
Read now
. (2004) Chemokine receptor antagonists as HIV entry inhibitors. Expert Opinion on Therapeutic Patents 14:2, pages 251-255.
Read now
WI de Boer. (2003) Potential new drugs for therapy of chronic obstructive pulmonary disease. Expert Opinion on Investigational Drugs 12:7, pages 1067-1086.
Read now
K Noel Masihi. (2003) Progress on novel immunomodulatory agents for HIV-1 infection and other infectious diseases. Expert Opinion on Therapeutic Patents 13:6, pages 867-882.
Read now

Articles from other publishers (35)

Yoon Hyeun Oum, Steven A. Kell, Younghyoun Yoon, Zhongxing Liang, Pieter Burger & Hyunsuk Shim. (2020) Discovery of novel aminopiperidinyl amide CXCR4 modulators through virtual screening and rational drug design. European Journal of Medicinal Chemistry 201, pages 112479.
Crossref
Xilun Anthony Wang, Katherine Griffiths & Michael Foley. 2020. Anti-fibrotic Drug Discovery. Anti-fibrotic Drug Discovery 211 234 .
Theresa Gaines, Francisco Garcia, Saniya Virani, Zhongxing Liang, Younghyoun Yoon, Yoon Hyeun Oum, Hyunsuk Shim & Suazette Reid Mooring. (2019) Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors. European Journal of Medicinal Chemistry 181, pages 111562.
Crossref
Renren Bai, Xiaokang Jie, Jian Sun, Zhongxing Liang, Younghyoun Yoon, Amber Feng, Yoonhyeun Oum, Wenyan Yu, Rui Wu, Bin Sun, Eric Salgado, Yuanyuan Xie & Hyunsuk Shim. (2019) Development of CXCR4 modulators based on the lead compound RB-108. European Journal of Medicinal Chemistry 173, pages 32-43.
Crossref
Renren Bai, Jian Sun, Zhongxing Liang, Younghyoun Yoon, Eric Salgado, Amber Feng, Yoonhyeun Oum, Yuanyuan Xie & Hyunsuk Shim. (2018) Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives. European Journal of Medicinal Chemistry 150, pages 195-205.
Crossref
Raymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova, David Maussang, Pasquale Cutolo, Beatrijs Strubbe, Henry F. Vischer, Françoise Bachelerie & Martine J. Smit. (2017) CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome. Journal of Pharmacology and Experimental Therapeutics 363:1, pages 35-44.
Crossref
Renren Bai, Zhongxing Liang, Younghyoun Yoon, Eric Salgado, Amber Feng, Saumya Gurbani & Hyunsuk Shim. (2017) Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study. European Journal of Medicinal Chemistry 136, pages 360-371.
Crossref
James C. Dabrowiak. 2017. Metals in Medicine. Metals in Medicine 285 327 .
Renren Bai, Qi Shi, Zhongxing Liang, Younghyoun Yoon, Yiran Han, Amber Feng, Shuangping Liu, Yoonhyeun Oum, C. Chris Yun & Hyunsuk Shim. (2017) Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library. European Journal of Medicinal Chemistry 126, pages 464-475.
Crossref
Mamoru Morimoto, Yoichi Matsuo, Shuji Koide, Ken Tsuboi, Tomoya Shamoto, Takafumi Sato, Kenta Saito, Hiroki Takahashi & Hiromitsu Takeyama. (2016) Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists. BMC Cancer 16:1.
Crossref
Theresa Gaines, Davita Camp, Renren Bai, Zhongxing Liang, Younghyoun Yoon, Hyunsuk Shim & Suazette Reid Mooring. (2016) Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors. Bioorganic & Medicinal Chemistry 24:21, pages 5052-5060.
Crossref
Renren Bai, Zhongxing Liang, Younghyoun Yoon, Shuangping Liu, Theresa Gaines, Yoonhyeun Oum, Qi Shi, Suazette Reid Mooring & Hyunsuk Shim. (2016) Symmetrical bis-tertiary amines as novel CXCR4 inhibitors. European Journal of Medicinal Chemistry 118, pages 340-350.
Crossref
Anna Junker, Dirk Schepmann, Junichiro Yamaguchi, Kenichiro Itami, Andreas Faust, Klaus Kopka, Stefan Wagner & Bernhard Wünsch. (2014) Diverse modifications of the 4-methylphenyl moiety of TAK-779 by late-stage Suzuki–Miyaura cross-coupling. Org. Biomol. Chem. 12:1, pages 177-186.
Crossref
Anna Junker, Junichiro Yamaguchi, Kenichiro Itami & Bernhard Wünsch. (2013) Synthesis of Thiophene-Based TAK-779 Analogues by C–H Arylation. The Journal of Organic Chemistry 78:11, pages 5579-5586.
Crossref
Hai-bo Shen, Zheng-qin Gu, Kang Jian & Juan Qi. (2013) CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer. Tumor Biology 34:3, pages 1839-1845.
Crossref
Xuan Tang & Xiangyang Liang. (2013) Metal-mediated Targeting in the Body. Chemical Biology & Drug Design 81:3, pages 311-322.
Crossref
James C. Dabrowiak. 2009. Metals in Medicine. Metals in Medicine 219 249 .
Claudiu T. Supuran & Jean‐Yves Winum. 2009. Drug Design of Zinc‐Enzyme Inhibitors. Drug Design of Zinc‐Enzyme Inhibitors 981 987 .
Hyunsuk Shim, Shinya Oishi & Nobutaka Fujii. (2009) Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors. Seminars in Cancer Biology 19:2, pages 123-134.
Crossref
Antonio MastrolorenzoAlfonso MarescaStefano RusconiClaudiu T Supuran. (2008) Update on the development of HIV entry inhibitors. Future HIV Therapy 2:5, pages 479-507.
Crossref
Hirokazu TamamuraHiroshi TsutsumiWataru NomuraNobutaka Fujii. (2008) Exploratory Studies on Development of the Chemokine Receptor CXCR4 Antagonists toward Downsizing. Perspectives in Medicinal Chemistry 2, pages PMC.S422.
Crossref
Weiqiang Zhan, Zhongxing Liang, Aizhi Zhu, Serdar Kurtkaya, Hyunsuk Shim, James P. Snyder & Dennis C. Liotta. (2007) Discovery of Small Molecule CXCR4 Antagonists. Journal of Medicinal Chemistry 50:23, pages 5655-5664.
Crossref
Xiangyang Liang, Dominic J. Campopiano & Peter J. Sadler. (2007) Metals in membranes. Chemical Society Reviews 36:6, pages 968.
Crossref
Hiroshi Tsutsumi, Tomohiro Tanaka, Nami Ohashi, Hiroyuki Masuno, Hirokazu Tamamura, Kenichi Hiramatsu, Takanobu Araki, Satoshi Ueda, Shinya Oishi & Nobutaka Fujii. (2006) Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents. Peptide Science 88:2, pages 279-289.
Crossref
Patrick Dorr, Mike Westby, Susan Dobbs, Paul Griffin, Becky Irvine, Malcolm Macartney, Julie Mori, Graham Rickett, Caroline Smith-Burchnell, Carolyn Napier, Rob Webster, Duncan Armour, David Price, Blanda Stammen, Anthony Wood & Manos Perros. (2005) Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity. Antimicrobial Agents and Chemotherapy 49:11, pages 4721-4732.
Crossref
Clemens Esche, Cristiana Stellato & Lisa A. Beck. (2005) Chemokines: Key Players in Innate and Adaptive Immunity. Journal of Investigative Dermatology 125:4, pages 615-628.
Crossref
F. Dorp, B. Wullich, E. Gulbins & A. Eisenhardt. (2005) Molekularbiologische Erklärungsansätze einer LymphknotenmetastasierungMolecular biology approach to explain lymphatic metastasis. Der Urologe, Ausgabe A 44:6, pages 608-613.
Crossref
Candace Gomez & Thomas J. Hope. (2005) The ins and outs of HIV replication. Cellular Microbiology 7:5, pages 621-626.
Crossref
Jean‐Yves Winum, Andrea Scozzafava, Jean‐Louis Montero & Claudiu T. Supuran. (2004) Sulfamates and their therapeutic potential. Medicinal Research Reviews 25:2, pages 186-228.
Crossref
Linda Bendall & Kenneth Bradstock. 2005. Chemokines, Chemokine Receptors, and Disease. Chemokines, Chemokine Receptors, and Disease 331 365 .
K. Noel Masihi. 2005. Principles of Immunopharmacology. Principles of Immunopharmacology 377 390 .
Heidi V. Russell, John Hicks, M.Fatih Okcu & Jed G. Nuchtern. (2004) CXCR4 Expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. Journal of Pediatric Surgery 39:10, pages 1506-1511.
Crossref
Theodore C. Pierson, Robert W. Doms & Stefan Pöhlmann. (2004) Prospects of HIV‐1 entry inhibitors as novel therapeutics. Reviews in Medical Virology 14:4, pages 255-270.
Crossref
Anandan Palani, Sherry Shapiro, John W. Clader, William J. Greenlee, Susan Vice, Stuart McCombie, Kathleen Cox, Julie Strizki & Bahige M. Baroudy. (2003) Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides. Bioorganic & Medicinal Chemistry Letters 13:4, pages 709-712.
Crossref
Anandan Palani, Sherry Shapiro, John W. Clader, William J. Greenlee, David Blythin, Kathleen Cox, Nicole E. Wagner, Julie Strizki, Bahige M. Baroudy & Niya Dan. (2003) Biological evaluation and interconversion studies of rotamers of SCH 351125, an orally bioavailable CCR5 antagonist. Bioorganic & Medicinal Chemistry Letters 13:4, pages 705-708.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.